|
Report Date : |
27.04.2012 |
IDENTIFICATION DETAILS
|
Name : |
SIGMATEC PHARMACEUTICAL INDUSTRIES SAE |
|
|
|
|
Registered Office : |
6th Industrial
Zone, Plot B/1, |
|
|
|
|
Country : |
|
|
|
|
|
Year of Establishment : |
2007 |
|
|
|
|
Legal Form : |
Egyptian Joint Stock Company |
|
|
|
|
Line of Business : |
Manufacture of pharmaceutical capsules and vials. |
|
|
|
|
No. of Employees : |
2,500 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
Egypt |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company Name : SIGMATEC PHARMACEUTICAL INDUSTRIES SAE
Country of Origin : Egypt
Legal Form : Egyptian Joint Stock Company
Registration Date : 2007
Issued Capital : £E 50,000,000
Paid up Capital : £E 50,000,000
Total Workforce : 2,500
Activities : Manufacture of pharmaceutical capsules and vials.
Financial Condition : Undetermined
Payments : Nothing detrimental uncovered
Person Interviewed : Mohmoud Al Najjar, Administration Secretary
SIGMATEC PHARMACEUTICAL
INDUSTRIES SAE
Registered &
Physical Address
Location : 6th Industrial Zone,
Plot B/1, Giza
Town : 6th of October
City
Country : Egypt
Telephone : (20-2) 38278740 / 38278741 / 38278742
/ 38278744
Facsimile : (20-2) 38278760 / 38278760
Mobile : (20-111) 6966660 / 6114433 / 66
/ 77 / 88 / 99
Email : m-elenna@sigm-corp.net / loui@sigma-corp.net / elnajjar@sigmapharm.net
Premises
Subject operates
from a large suite of offices and a factory that are rented and located in the
Industrial Area of 6th of October City.
Name Position
·
Dr
Sayad El Badawi Chairman
·
Dr
Mohsen El Enaa Vice
Chairman
·
Dr Atef
Deraaz Director
·
Dr
Ahmed Habib Director
·
Dr Loui
El Halabi Export
Manager
·
Dr
Mohamed Khattab Marketing
Manager
·
Wahid
Helmy Finance
Manager
·
Hamdy
Hussain Accounts
Manager
·
Mohmoud
Al Najjar Administration
Secretary
Date of Establishment : 2007
Legal Form :
Egyptian Joint Stock
Company
Issued Capital : £E 50,000,000
Paid up Capital : £E 50,000,000
Name of Shareholder
(s)
·
Sigma
Group
Egypt
·
Dr
Sayad El Badawi
·
Dr
Mohsen El Enaa
·
Dr Atef
Deraaz
·
Dr
Ahmed Habib
·
Sigma
Pharmaceuticals Industries
Quesna
Activities: Engaged in the manufacture of
pharmaceutical capsules and vials.
Subject is ISO 9001 accredited.
Import
Countries: Europe and the
Far East.
Subject has a
workforce of approximately 2,500 employees.
Companies
registered in Egypt are not legally required to make their accounts public and
no financial information was released by the company or submitted by outside
sources.
·
Export
Development Bank of Egypt
Plot 3/1
4th Industrial Region
6th of October City
Tel: (20-11) 38330577 / 38330599
Fax: (20-11) 38330570 / 38330551
No complaints
regarding subject’s payments have been reported.
During the course
of this investigation nothing detrimental was uncovered regarding subject’s
operating history or the manner in which payments are fulfilled. As such the company
is considered to be a fair trade risk.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.52.57 |
|
UK Pound |
1 |
Rs.85.03 |
|
Euro |
1 |
Rs.69.56 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.